💨 Abstract
Eli Lilly plans to introduce its diabetes drug, Mounjaro, in countries including China, India, Brazil, and Mexico by 2026, as per the company's Chief Financial Officer, Lucas Montarce, at the Leerink Partners Global Healthcare Conference.
Courtesy: theprint.in
Summarized by Einstein Beta 🤖
Suggested
RBI will push payment systems innovations with soft touch regulations: Guv
Mohammedan Sporting end debut ISL campaign without a home win after 2-2 draw against Punjab FC
Haryana to meet Jharkhand in Senior Women National Hockey Championship
Indian naval ship Imphal reaches Mauritius to participate in national day celebrations
Stones pelted at ED vehicles after raid at Bhupesh Baghel's residence in Durg district
ASI employee count at 4,845 against sanctioned strength of 8,755: Govt
Stocks drop with Treasury yields as Trump interview fuels growth worries
Eli Lilly plans launch of weight-loss drug in emerging markets in 2025, CFO says
Eli Lilly plans to launch Mounjaro in China, India, Brazil and Mexico in 2025, CFO says
Musk's X facing intermittent outages in US, Downdetector shows
Powered by MessengerX.io